Edwards Lifesciences (EW) Inventory Average (2010 - 2026)

Edwards Lifesciences has reported Inventory Average for 17 years, with the latest figure at $1.1 billion in Q2 2026.

• On a quarterly basis, Inventory Average changed 0.24% year-over-year to $1.1 billion in Q2 2026; TTM through Jun 2026 was $1.1 billion, a 0.24% change from a year earlier, with the FY2025 full-year figure at $1.1 billion, up 11.19% from the prior year.
• Inventory Average was $1.1 billion for Q2 2026 at Edwards Lifesciences, roughly flat from $1.1 billion in the prior quarter.
• The five-year high for Inventory Average was $1.1 billion in Q3 2025, with the low at $728.6 million in Q1 2022.
• Average Inventory Average over 5 years is $996.0 million, with a median of $1.1 billion recorded in 2024.
• The sharpest annual moves came in 2022 and 2023: Inventory Average fell 7.19% in 2022, then jumped 34.37% in 2023.
• Over 5 years, Inventory Average stood at $816.6 million in 2022, then gained by 18.53% to $968.0 million in 2023, then rose by 13.17% to $1.1 billion in 2024, then grew by 3.48% to $1.1 billion in 2025, then decreased by 0.75% to $1.1 billion in 2026.
• The last three Inventory Average figures came in at $1.1 billion (Q2 2026), $1.1 billion (Q1 2026), and $1.1 billion (Q4 2025), per Business Quant data.